Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Silver

Showing results (81-90 of 174) with videos related to

Pageof 18
Sort By:
Archives of Dermatology|September 1, 1990
Scleroderma following augmentation mammoplasty. Report of a case and review of the literatureE E Sahn, P D Garen, R M Silver, et al.
The British Journal of Dermatology|February 24, 2012
Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutières syndromeV Tüngler, R M Silver, H Walkenhorst, et al.
Clinical and Experimental Rheumatology|January 11, 2005
Myofibroblast induction and microvascular alteration in scleroderma lung fibrosisM Beon, R A Harley, A Wessels, et al.
The International Journal of Biochemistry & Cell Biology|January 1, 1997
Increased activity of the alpha 1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndromeE G Hitraya, S A Jimenez, A Ludwicka, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 29, 1998
Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid InteractionA E Gharavi, E Cucurull, H Tang, et al.
Neurotoxicology and Teratology|September 1, 1996
Cognitive deficits in a murine model of the eosinophilia-myalgia syndrome: a preliminary reportL D Middaugh, R Nussbaum, A Ludwicka, et al.
Arthritis and Rheumatism|April 1, 1997
Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosisM B Bolster, A Ludwicka, S E Sutherland, et al.
Arthritis and Rheumatism|July 1, 1989
A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?E C Leroy, E A Smith, M B Kahaleh, et al.
American Journal of Obstetrics and Gynecology|September 16, 1999
Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndromeR M Lee, W Emlen, J R Scott, et al.
The Journal of Rheumatology|November 11, 1999
Solvent oriented hobbies and the risk of systemic sclerosisP J Nietert, S E Sutherland, R M Silver, et al.
Pageof 18

Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
Archives of Dermatology|September 1, 1990
Scleroderma following augmentation mammoplasty. Report of a case and review of the literatureE E Sahn, P D Garen, R M Silver, et al.
The British Journal of Dermatology|February 24, 2012
Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutières syndromeV Tüngler, R M Silver, H Walkenhorst, et al.
Clinical and Experimental Rheumatology|January 11, 2005
Myofibroblast induction and microvascular alteration in scleroderma lung fibrosisM Beon, R A Harley, A Wessels, et al.
The International Journal of Biochemistry & Cell Biology|January 1, 1997
Increased activity of the alpha 1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndromeE G Hitraya, S A Jimenez, A Ludwicka, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 29, 1998
Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid InteractionA E Gharavi, E Cucurull, H Tang, et al.
Neurotoxicology and Teratology|September 1, 1996
Cognitive deficits in a murine model of the eosinophilia-myalgia syndrome: a preliminary reportL D Middaugh, R Nussbaum, A Ludwicka, et al.
Arthritis and Rheumatism|April 1, 1997
Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosisM B Bolster, A Ludwicka, S E Sutherland, et al.
Arthritis and Rheumatism|July 1, 1989
A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?E C Leroy, E A Smith, M B Kahaleh, et al.
American Journal of Obstetrics and Gynecology|September 16, 1999
Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndromeR M Lee, W Emlen, J R Scott, et al.
The Journal of Rheumatology|November 11, 1999
Solvent oriented hobbies and the risk of systemic sclerosisP J Nietert, S E Sutherland, R M Silver, et al.
Pageof 18